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Background/objectives: The vascular heterogeneity of pancreatic ductal adenocarcinoma (PDAC) has
never been characterised. We analysed the heterogeneous vascular density of human PDAC along with its
prognostic correlation.
Methods: Tissue Microarrays of 87 patients with different pancreatico-biliary pathologies were analysed
in an automated manner (Ariol™) after CD31 staining to assess vascular density in juxta-tumoral and
panstromal compartments. In vitro and ex vivo assays were carried out to assess the role of PSC.
Results: PDAC has a distinct vascular density and distribution of vessels compared to chol-
angiocarcinoma. The PDAC juxta-tumoral stroma was hypovascular and the normal adjacent rim was
hypervascular compared to the panstromal compartment. These features adversely affected patient
prognosis, suggesting a model for spatio-temporal PDAC evolution. Mice aortic rings and 3D organotypic
cultures demonstrated pro- and anti-angiogenic signalling from activated PSC and cancer cells respec-
tively. ATRA-induced quiescence suppressed the pro-angiogenic activity of PSC.
Conclusion: Human PDAC has variable vascularity at microscopic level suggesting that novel stromal
directed therapies would need to be determined by pathological characteristics.
© 2016 IAP and EPC. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Pancreatic ductal adenocarcinoma (PDAC) is characterised by
loss of acino-lobular architecture, progressive subversion of the
stromal/epithelial ratio and extracellular matrix (ECM) deposition
[1]. Pancreatic stellate cells (PSC) are the conductors of the micro-
environmental disruption contributing to PDAC growth, early in-
vasion and dismal prognosis [1,2]. The hypovascular attribute of
PDAC is routinely utilised in the clinic for its diagnosis by imaging
such as CT scan [3]. The hypovascular nature and diffuse ﬁbrosis is
also noted at histological examination [4]. In fact, this aspect has
been highlighted in experimental conditions to account for lack of
therapeutic effect of chemo- and radio-therapy [4e6].
The desmoplastic stroma is a dynamic temporally and spatially
distinct compartment of PDAC that is critically involved in tumourLondon, Centre for Tumour
ellence, Charterhouse Square,
r).
r B.V. This is an open access articleformation and progression and may inﬂuence the vascularity. Our
recent studies have revealed a differential inﬂammatory inﬁltrate
in the juxta-tumoral (<100 mm) and pan-stromal compartment in
the human PDAC, which may be due to multitude of cytokines,
chemokines and adhesion molecules produced by this desmo-
plastic stroma [7e10]. We postulated that these differences be-
tween the stromal sub-compartments may also exist for vascular
density. Here, we demonstrate that pancreatic stellate cells (PSC)
are responsible for the changes in the observed tumoral and stro-
mal sub-compartmental vascular density, which may be of prog-
nostic relevance.2. Materials and methods
2.1. Tissue microarray analyses
Tissue microarrays (TMAs) were constructed with pancreatic
tissues from 87 HPB (Hepato-Pancreatico-Biliary) patients sub-
jected to pancreatic resection (Supplementary Table 1) at Barts
Health NHS Trust (City and East London Research Ethics Committeeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
F. Di Maggio et al. / Pancreatology 16 (2016) 995e100499607/0705/87) as described previously [7]. Regions of tumour, stroma,
and normal pancreas were marked on H&E-stained slides of the
donor tissue blocks, and three 1-mm cores of each region were
sampled per patient using the Tissue Arrayer Minicore 3 (Alphelys,
Plaisir, France). TMAs were stained with CD31 antibody (Rabbit anti
Human ab28364 Abcam, Cambridge, MA) for the presence of
vascular structures. Micro Vascular Density (MVD ¼ number of
vessels/mm2) and Total Vascular Area (TVA ¼ area occupied by
vascular structures as proportion of the total area expressed in/
1000 or ‰) were considered as indices of vascularisation [11e13].
The Ariol™ imaging analysis system (Genetix, New Milton, En-
gland) was used to determine vascular indices. Brieﬂy, software is
trained by the user to distinguish and quantify positive cells by
their colour, shape and size as described previously [7]. Cores were
initially divided into “normal” (derived from patients) with other
malignancies such as duodenal cancers or neuroendocrine tumours
(pancreas more than 1 cm from tumour mass), “cancer” and
“stroma” (the latter being cancer patients' tissues containing no
epithelial component) for PDAC or cholangiocarcinoma.
PDAC-associated stroma was then divided into “juxta-tumoral”
(100 mm from the epithelial cancer component) and “pan-stro-
mal” [7]. The juxtatumoral compartment was marked using imag-
ing callipers on all TMA cores. The panstromal vascular density was
calculated by subtracting the tumoural and juxtatumoral area from
each TMA core and then dividing the relevant number of vessels by
it. Ariol™ software detects the surface area occupied by structures
measured. Finally, microscopically healthy looking tissues (ob-
tained from PDAC patients) surrounding tumours were also ana-
lysed (normal adjacent) and compared to the other groups. The
median values of all analysed tumour cores for each patient within
different TMA regions were used to determine the prognostic
impact of all the indices.
2.2. Isolation of PS-1, human telomerase reverse transcriptase,
immortalization of PS-1 cells
Using the outgrowth method pancreatic stellate cells were iso-
lated from an unused donated human pancreas (donation for
transplantation) by the UK Human Tissue Bank (Ethics approval;
Trent MREC, 05/MRE04/82). The resulting cell strain, designated
PS-1, was veriﬁed as being of stellate cell origin (grown in E4:F12
medium). PS-1 cells were immortalized by 24 h incubation with
retroviruses containing cDNA encoding human telomerase reverse
transcriptase (hTERT) derived from the AM12 packaging cell line
(AM12-hTERT) with empty-vector transduced controls and
selected with 1 g/ml puromycin. Immortalized cell telomerase ac-
tivity was ascertained by the TRAP assay (Telomerase Repeat
Ampliﬁcation Protocol, Oncor, Inc.; manufacturer's instructions).
2.3. Cell cultures and organotypic cultures
PSC (Pancreatic Stellate Cells) and PCC (Pancreatic Cancer Cells)
such as Capan1, Colo357 and AsPc1 were cultured in a standard
manner as described before [10]. Human Umbilical Vein Endothe-
lial Cells (HUVEC) hTERT (a kind gift from Prof Tahara [14]) were
cultured in HUVEC Cells Medium (HCM): M199 þ 0.25%
Heparinþ 20% FBSþ 1% Penicillin/Streptomycinþ 0.5% Endothelial
Cells Growth Supplement (ECGS e Sigma Aldrich). HUVEC were co-
cultured with cancer cells or stellate cells (activated or ATRA-
treated) in organotypic 3D gels. Pancreatic cancer organotypic
cultures were constructed as described previously [15], with some
modiﬁcations introduced to successfully co-culture HUVEC. Brieﬂy,
1 mL of solution constituted of 0.35 mL Type 1 Collagen, 0.35 mL
Matrigel™, 0.2 mL HCM containing 5  105 HUVEC and 0.1 mL FBS
containing 5  105 PSC was poured in a collagen pre-coated well ofa 24-well plate. For triple cultures (HUVEC, PSC and PCC) cancer
cells were added the following day suspended in the feeding
medium.
Cell growth was monitored for the following seven days with
dual-phase microscope. HUVEC survival, early sprouting and for-
mation of vessel-like structures were monitored. Gels were har-
vested on day seven, ﬁxed in formal-saline, embedded in parafﬁn
and cut into 4 mm sections for H&E staining and immunostaining.
2.4. All trans retinoic acid (ATRA) treatment
ATRA (Sigma-Aldrich, Dorset, England) were dissolved in 100%
ethanol and used as described before [9]. PSCs were rendered
quiescent after treatment with 1 mM ATRA dissolved in medium for
seven consecutive days as described before [9].
2.5. Immunostaining
Parafﬁn embedded organotypic sections were dewaxed and
rehydrated. Heat induced epitope retrieval in citrate buffer (pH¼ 6)
was used for all antibodies. Sections were permeabilized with 0.2%
TritonX-100 and blocked with 2% bovine serum albumin (#K45-
001; PAA laboratories), 0.02% ﬁsh skin gelatin (#G7765; Sigma),10%
FBS (#A15-104; PAA laboratories).
Primary antibodies were incubated at 4 C overnight.
Fluorescent-labelled appropriate secondary antibodies (Alexa
ﬂuor® 488, 546) were incubated at room temperature for 1 h and
nuclei were counterstained with DAPI. Controls were uniformly
negative with appropriate isotype-speciﬁc immunoglobulin at
matching dilution. Images were acquired and analysed using
confocal microscopy (Carl Zeiss LSM 510).
2.6. Mice aortic rings angiogenesis assay
In order to study the angiogenic potential of the different cell
lines the ex vivo mice aortic rings angiogenesis assay was per-
formed as described before [16], with Institutional Review Board
approval. Brieﬂy, 12e16 weeks old wild type mice were sacriﬁced
and aorta was surgically removed, cleaned, cut in rings (approxi-
mately 20 rings/aorta measuring 500 mm diameter) and incubated
overnight in medium (OPTIMEM þ Glutamax þ 2.5% FBS, used
throughout the experiment) at 37, 5% CO2. The following day rings
were embedded in solutions containing variable concentrations of
Collagen (0.5 mg/ml, 1 mg/ml, 2 mg/ml and 4 mg/ml). On days one,
four and seven the rings were fed with conditioned medium from
AsPC1, Capan1, COLO357, activated or ATRA-treated PSCs with care
being taken to ensure that the cell number is equal (ATRA-treated
PSC proliferate slowly). To obtain conditioned medium from the
above-mentioned cell lines, they were cultured in Opti-
Mem þ Glutamax þ 2.5% FBS for 24 h (the same medium used as
negative control). Supernatant was then centrifuged, ﬁltered and
immediately used to feed the rings (Supplementary Fig. 1).
Sprouting angiogenesis was quantiﬁed in all groups at days 6, 8
and 10 under dual-phase microscope. Rings were stained with
Bandeiraea simplicifolia (BSI) Lectin-FITC (L9381 Sigma-Aldrich) and
a-sma-CY3 (C619B Sigma-Aldrich) to obtain confocal images of the
vascular structures as well as the supporting cells [16]. All experi-
ments were run in triplicate.
2.7. Statistical analysis
Statistical analysis and graphical data representation were done
using the software PRISM V.6 (Graphpad, La Jolla, USA). The
normality of the distribution of the data was determined using
D'Agostino & Pearson normality test. Summary data are expressed
F. Di Maggio et al. / Pancreatology 16 (2016) 995e1004 997as the median with interquartile range (non-Gaussian distribu-
tions). Comparisons between different groups were performed
using One-way ANOVA test with either Kruskal-Wallis or Friedman
test for multiple comparisons, and Mann Whitney U test for two
groups. Kaplan-Meier survival curves were generated for survival
analyses using the Log Rank or Gehan-Breslow-Wilcoxon test. The
level of signiﬁcance was set at p < 0.05.3. Results
3.1. Stroma speciﬁc hypovascularity of human PDAC
TMA Ariol™ analyses of normal pancreas, cholangiocarcinoma
and PDAC tissues from 87 patients revealed signiﬁcant differences
in microvascular density (MVD), total vascular area (TVA), di-
mensions and distribution of vessels between normal and different
cancer tissues (Fig. 1). Interestingly, the PDAC stromal compart-
ment, but not cholangiocarcinoma stromal compartment, was
signiﬁcantly less vascular than either normal or tumoral tissue as
measured by either MVD or TVA.
Within the PDAC stroma, the juxtatumoral stroma (<100 mm of
tumour, Fig. 2A) had signiﬁcantly less vessel density (MVD) than
either the panstromal compartment or normal pancreas. MVD for
normal pancreas and panstromal compartment were similar
(Fig. 2B). Surprisingly, there was no difference when comparing
normal pancreas and juxtatumoral total vascular area (TVA)
(Fig. 2C). We hypothesised that these subtle differences may be due
to the differential distribution of vessels with different calibres. TheFig. 1. Stroma is hypovascular in PDAC but not cholangiocarcinoma. AeC: CD31 immuno-hi
with normal pancreas (A), PDAC (B) and cholangiocarcinoma (C). Scale Bar ¼ 100 mm. D-E Th
vascular area (TVA, E) was measured by area occupied by vessels per 1000 units of area usi
summary data are shown in the form of box (median and interquartile ranges) and whiske
which was derived as a median value of three to six microarray cores. Statistical analyses we
signiﬁcant, *p < 0.05, **P < 0.01, ***p < 0.001.dimensional spectrum of vessels in the healthy tissue was homo-
geneous and normally distributed as compared to tumoral stroma
which had a skewed distribution (Fig. 2D). Whilst both stromal
compartments demonstrate a heterogeneous vascular architecture,
it is possible that in the juxta-tumoral stroma the microvessels are
compressed by the dense stroma (Fig. 2E).
We subsequently analysed those areas, within samples coming
from cancer patients, looking microscopically normal (preserved
acinar structure) but in close proximity to the cancer surrounding
stroma. Remarkably, this normal adjacent tissue was hyper-
vascularised compared to all the tissue sub-compartments previ-
ously analysed (Fig. 3). Indeed, bothmicro vascular density (3C) and
total vascular area (3D) of normal adjacent tissue resulted signiﬁ-
cantly higher than the correspondent values we had calculated in
the tissue coming from healthy donors.
Thus, microscopic vascular distribution in PDAC does not
resemble the symmetry of the cognate normal, functional organ or
the heterogeneity seen on other cancers, affecting the same organ,
such as cholangiocarcinoma. We postulated that these subtle
stromal compartment differences may be because of the presence
of activated pancreatic stellate cells (PSC) or immense extra-cellular
matrix deposition in PDAC stroma.3.2. Aortic ring angiogenesis assay
Ex vivo angiogenesis assays using mice aortic rings experiments
demonstrated a pro-angiogenic feature of activated pancreatic
stellate cells (aPSC) and signiﬁcant anti-angiogenic inﬂuencestochemistry (brown) was used to demonstrate vascular density in tissue micro-arrays
e micro-vascular density (MVD, D) was measured by number of vessels/mm2. The total
ng automated Ariol™ analysis for the tumour bearing and stromal areas of cancer. The
r (95% range) graphs. Each data-point represents a patient (numbers depicted by n¼),
re performed by Kruskal-Wallis test with Dunn's post-hoc multiple comparison. ns, not
Fig. 2. Vascular density of stromal sub-compartments. A: Juxtatumoral stroma (within 100 mm of tumour tissue) and panstroma (the rest of the tumour stroma) were deﬁned using
the Ariol™ software to perform separate analyses for vascular density. Scale Bar ¼ 100 mm. B, C: The micro-vascular density (MVD, D) was measured by number of vessels/mm2. The
total vascular area (TVA, E) was measured by area occupied by vessels per 1000 units of area using automated Ariol™ analysis for the stromal cub-compartments areas of PDAC. The
summary data are shown in the form of box (median and interquartile ranges) and whisker (95% range) graphs. Each data-point represents a measurement from individual core. In
case of multiple spots analysed within the same core (for Juxtatumoral only) the median of the index measurement per core was used. Statistical analyses were performed by
Kruskal-Wallis test with Dunn's post-hoc multiple comparison. ns, not signiﬁcant, *p < 0.05, **P < 0.01, ***p < 0.001. D: The dimension of each vessel was measured. The summary
data are shown in the form of box (median and interquartile ranges) and whisker (95% range) graphs. Each data-point represents a vessel (number, n¼) on a graph with logarithmic
Y-axis scale. Statistical analysis was performed by Kruskal-Wallis test with Dunn's post-hoc multiple comparison. **P < 0.01, ***p < 0.001. E. The proportion of capillaries
(5.5e20 mm) is the highest in normal tissue, whereas in tumour stroma arteries (100e500 mm) and arterioles (20e100 mm) are more prevalent. In juxta-tumoral stroma very small
capillaries (<5 mm) account for 3e4% of total and may represent non-functional vessels compressed by the dense stroma.
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Fig. 3. Normal adjacent pancreas is more vascularised in PDAC. A, B: Histopathological image of normal pancreas adjacent to PDAC showing higher vascular density, as identiﬁed by
CD31 immuno-histochemistry. Scale Bar: 100 mm. C, D: The micro-vascular density (MVD, C) was measured by number of vessels/mm2. The total vascular area (TVA, D) was
measured by area occupied by vessels per 1000 units of area using automated Ariol™ analysis for the normal adjacent areas in PDAC and normal pancreas. The summary data are
shown in the form of box (median and interquartile ranges) and whisker (95% range) graphs. Each data-point is a selected area analysed. Statistical analysis by Mann-Whitney U
test. **P < 0.01.
F. Di Maggio et al. / Pancreatology 16 (2016) 995e1004 999exerted by cancer cells (Fig. 4AeE). Rendering PSC quiescent with
ATRA [9] reversed this pro-angiogenic effect (Fig. 4HeJ). Immu-
noﬂuorescent staining of the rings conﬁrmed the vascular nature of
the sprouts (Fig. 4K): endothelial cells were BSI-Lectin positive,
support cells and pericytes were aSMA-positive [16].
Progressively increasing concentrations of collagen within the
embedding gel inﬂuences the formation of sprouts in a bimodal
effect, intermediate concentrations being the most suitable for
angiogenesis, as reported in the past [17,18] (Supplementary Fig. 2).
3.3. 3D organotypic cultures
HUVEC cells, in the appropriate collagen/Matrigel 3D mixture
demonstrated the ability of early sprouting (Fig. 5A) at 48 h and
aggregating to form luminal structures at 72 h 3D organotypic co-
cultures demonstrated strong anti-angiogenic signalling frompancreatic cancer cells (PCC). Indeed, the presence of PCC inhibited
endothelial cells survival both in the ‘double’ HUVEC-PCC and the
‘triple’ HUVEC-PCC-PSC organotypic cultures (Fig. 5E). There was
almost no endothelial cells detectable 48e72 h after the co-culture
started with any of cancer cell lines tested (Fig. 5 C and D). On the
other hand, HUVEC were not only detectable, but also sprouting
(Fig. 5B) and assembling in luminal structures (Fig. 5J) in the
presence of aPSC. Von-Willebrand factor immuno-ﬂuorescent
staining conﬁrmed the vascular nature of the circular vessel like
aggregations of HUVEC in 3D (Fig. 5G). The number of endothelial
cells (von Willebrand factor positive) present 72 h after 3D double
cultures was signiﬁcantly lower when HUVEC were co-cultured
with PCC than with PSC (Fig. 5F). ATRA-induced stellate cells
quiescence suppressed this pro-angiogenic activity, together with
the previously shown capacity to shrink the organotypic gel
(Fig. 5H and I). Of note, a higher Collagen concentration in the gels
Fig. 4. Stellate cells promote angiogenesis in mice aortic rings whereas cancer cells inhibit it. AeD: Representative microscopic images of aortic rings treated with either VEGF
(30 ng/mL, positive control, A) [16], or conditioned medium from cancer cells (B), or negative controls (2.5% FBS supplemented media, C), or stellate cells (D) to demonstrate vessel
sprouts at endpoint analysis. Scale Bar ¼ 500 mm. E: The summary data of the aortic ring angiogenesis assays are shown in the form of box (median and interquartile ranges) and
whisker (95% range) graphs. Each data-point represents an aortic ring with experiments performed in multiple replicates [6e12] with at least three biological replicates. Statistical
analyses were performed by Kruskal-Wallis test with Dunn's post-hoc multiple comparison. *p < 0.05, **P < 0.01, ***p < 0.001. F, G: ATRA treated pancreatic stellate cells show a
quiescent morphology, whilst ethanol treated pancreatic stellate cells show the characteristic myoﬁbroblast-like morphology. Scale Bar ¼ 50 mm. H,I: Representative microscopic
images of aortic rings treated conditioned medium from ATRA-treated PSC (H) or activated PSC (I) at endpoint analysis. Scale Bar ¼ 500 mm (H) and 200 mm (I). J: The summary data
of the aortic ring angiogenesis assays are shown in the form of box (median and interquartile ranges) and whisker (95% range) graphs. Each data-point represents an aortic ring with
experiments performed in multiple replicates [6e12] with at least three biological replicates. Statistical analyses were performed by Kruskal-Wallis test with Dunn's post-hoc
multiple comparison. ***p < 0.001. K: Confocal microscope image of a sprout conﬁrming the vascular nature of the sprouts. Vascular structures are stained with BSI-Lectin and
supporting ﬁbroblasts (pericytes) with smooth muscle actin (SMA). Scale bar: 100 mm. See Supplementary Fig. 2 for other analysis on effect of Collagen concentration.
F. Di Maggio et al. / Pancreatology 16 (2016) 995e10041000[2] suppressed HUVEC survival (data not shown).
Taken together, these data draw the picture of a ﬁbrovascular
gradient, in which cancer cells signalling as well as dense ECM
contribute to render the juxtatumoural the less vascular compart-
ment, while activated stellate cells promote angiogenesis towards
the edges of the tumour mass.3.4. Impact on patient survival
Patient data are summarised in Supplementary Table 1. Three
patients experiencing postoperative mortality (<30 days) were
excluded from survival analysis. Brieﬂy, PDAC patients (n ¼ 63) had
worse prognosis than those with cholangiocarcinoma (n ¼ 19)
Fig. 5. Activated PSC promote HUVEC survival and angiogenesis in organotypic cultures. A: Early sprouting (24 h) of a single HUVEC cell in a 3D organotypic culture. BeD:
Representative images of sprouting HUVEC cells (arrows) in 3D double co-culture with PSC (B) or double culture with PCC (C) or triple HUVEC/PSC/PCC cultures (D) at 48 h after
starting the cultures. E: Summary data are mean þ SEM of sprouting HUVEC cells per ﬁeld analysed from multiple organotypic cultures as shown in BeD. 6 OT gels were cultured of
each condition. 10 independent ﬁelds were analysed for each double culture. Statistical analyses were performed by Friedman Test, *p < 0.05, **P < 0.01, ***p < 0.001). F, G; Von-
Willebrand Factor positive HUVEC (G) survived signiﬁcantly more in OT gels with HUVEC-PSC than HUVEC-PCC co-cultures. Summary data are mean þ SEM of sprouting cells per
ﬁeld analysed. 15 independent ﬁelds were analysed for each slide stained from a total of eight biological samples. Statistical analyses were performed by Friedman Test, ***p < 0.001.
HeJ: Circular structures resembling vessels were detectable after 72e96 h in organotypic gels with activated PSC-HUVEC (I) signiﬁcantly more than in gels with ATRA-treated PSC-
HUVEC (J). 12 double culture gels were analysed. Summary data are mean þ SEM of circular structures per ﬁeld analysed. Statistical analyses were performed by Friedman Test,
***p < 0.001.
F. Di Maggio et al. / Pancreatology 16 (2016) 995e1004 1001(median ¼ 403 vs 544 days, p ¼ 0.04). In PDAC patients, sex and
lymph involvement did not correlate directly with the prognosis,
whereas the well-differentiated grade was associated with a better
outcome (Supplementary Fig. 3).
The prognostic value of the vascular indices TVA and MVD wasanalysed within different areas of the neoplastic pancreas. Neither
the whole tumoral nor the whole stromal compartment vascular-
isation showed any statistical correlation with the outcome
(Fig. 6AeD). Two speciﬁc stromal compartments' (juxta-tumoral
stroma and normal adjacent tissue) vascular density (both MVD
Fig. 6. Juxtatumoral and normal adjacent vascular density impact on prognosis. Kaplan Meier curves were obtained after patients were divided either in three groups based on
quantiles which were high (above 3rd quartile), intermediate (between 1st and 3rd quartile), or low (below 1st quartile) for total vascular area (TVA) and microvascular density
(MVD). Comparisons were made by Log-rank (Mantel Cox) test. For each patient (number, n¼), data are obtained by calculating the average MVD and TVA measured within the
speciﬁc parenchymal area for that patient. AeD: Whole tumoral (A,B) and stromal (C,D) vascular density indices do not have prognostic impact, EeF: Higher juxtatumoral vascular
density indices for MVD (E) and TVA (F) result in better prognosis. G,H: For normal adjacent pancreas the data were analysed in two groups as high (above median) or low (below
median). Both vascular indices MVD (G) and TVA (H) in tumour adjacent normal tissues indicate higher vascularisation leads to poorer prognosis. See Supplementary Fig. 3 for other
analysis on cholangiocarcinoma.
F. Di Maggio et al. / Pancreatology 16 (2016) 995e10041002and TVA) impacted patient's prognosis. Interestingly, the increased
vascularisation of the juxtatumoral compartment was associated
with prolonged survival, whereas both enhanced MVD and TVA
within the normal adjacent tissue was associated with worse
prognosis (Fig. 6EeH).
These ﬁndings would conﬁrm the proposed model of develop-
ment of PDAC foci, based on a ﬁbrovascular gradient. For example,the most aggressive cancer exhibited the highest gradient i.e.,
having the less vascular juxtatumoral compartment and the most
vascular normal adjacent tissue.
4. Discussion
In this report, we demonstrate that the stromal sub-
F. Di Maggio et al. / Pancreatology 16 (2016) 995e1004 1003compartment speciﬁc vascularisation is different, and is clinically
relevant in human PDAC. Radiologically it has been noted that
intra-tumoral perfusion indices progressively increase from the
core to the outer rim of PDAC [17]. We suggest the activated
pancreatic stellate cells (PSC) may play a role in this differential
vascular density. We have previously demonstrated that increasing
the PSC proportion drives aggressive cancer behaviour, reiterating
the concept that cancer development is dynamic: cellular behav-
iour as well as ECM composition are subject to spatio-temporal
variations [1,32]. This, in turn, can dictate behaviour of other crit-
ical stromal cell populations such as immune cells. For example,
CD8þ cytotoxic T cells could not inﬁltrate juxta-tumoral sub-
compartment [7].
PSC's impact on angiogenesis possibly is dependent on their
activation status via modulation of secretome and the subsequent
ECM composition. PSC have been shown to secrete a number of
pro-angiogenic factors such as vascular endothelial growth factor
(VEGF) and Periostin among others in a hypoxia-dependent
manner. Activated PSC produce excessive amount of ECM pro-
teins, mainly Collagen and Fibronectin, contributing to dense
stroma which is anti-angiogenic [18e20]. In our models, activated
PSC stimulates endothelial cell growth in 3D ‘double’ cultures and
PSC supernatant induces aortic rings sprouting. We have also
shown that ATRA-induced PSC quiescence suppresses the PSC
angiogenic potential. Of note, the presence of cancer cells in ‘triple’
3D organotypic inﬂuences endothelial cells adversely, but does not
result in increases apoptosis (Supplementary Fig. 4), which in
conjunction with results from aortic rings demonstrate the anti-
angiogenic proﬁle of PCC. Previously we had demonstrated that
3D organotypic cultures of PSC and PCC, PSC activation by PCC can
alter the gel composition rendering them stiffer and contracted.
This effect might be mediated by secretion of collagen of ﬁbro-
nectin from activated PSC or enhanced cross-linkage of existing
Collagen [1,20]. Thus, eliciting the individual direct and indirect
contribution of PSC, PCC and ECM proteins, to name just the main
players, upon endothelial cell behaviour in the complex PDAC
micro-environment remains difﬁcult when all constituents are
admixed. Certainly targeting PSC does seem to alter the vascular
density in vivo [33].
Collagen has previously been demonstrated to be anti-
angiogenic in a number of assays [21,22]. In our organotypic
model, increasing relative concentration of collagen in the gel
adversely affected endothelial cells' survival. Similarly, increasing
the Collagen proportion in the embedding aortic rings gel, we
observed a signiﬁcant reduction in sprouts. Thus, rather than an
overall biological pro-angiogenic effect from the PSC secretome as
demonstrated by the aortic ring angiogenesis assays, PSC may play
a dynamic inﬂuence on pancreatic cancer vascularisation, by
modulating the ECM to spatio-temporally to inﬂuence the vascular
network.
In our experimental models, PCC (AsPC1, Colo357 and Capan1)
exerted a strong anti-angiogenic effect, inhibiting HUVEC survival
in 3D co-cultures as well as sprouting angiogenesis of mice aortic
rings. A similar effect was shown in 2D cultures by Erkan et al. and
was attributed to the PCC secretion of Endostatin, a strong anti-
angiogenic agent derived from Collagen degradation [23]. Para-
crine Endostatin secretion effect from PCC may explain the selec-
tive hypovascular nature of juxta-tumoral stroma.
However there are other possible molecular explanations for the
differential vascular distribution, and indeed all of them may
contribute in a spatio-temporal manner. Periostin, is expressed
almost exclusively in stroma and is undetectable in healthy
pancreatic [24]. Activated PSC secrete Periostin in PDAC [24,25] and
stimulate an auto-activation loop for PSC, promote cancer cells
survival under hypoxic conditions; thus create a tumour-supportive microenvironment [26]. Moreover, Periostin has been
shown to promote angiogenesis, and slow down the ECM turnover
inhibiting a number of matrix metalloproteinases (MMP) and
promoting the activity of tissue inhibitors of metalloproteinases
(TIMP) [26], placing Periostin to be an active player in tissue
remodelling. Notably, the deposition of Periostin from activated
PSC selectively happens towards the invasive front of the cancer
[24] and this may inﬂuence the angiogenic activity.
Similarly, L1CAM (Cell Adhesion Molecule L1) is deposited on
the invasive front of PDAC [27]. L1CAM recruits of endothelial cells
from the expanding tumour, as well as the invasiveness of cancer
cells [28]. These are possibly some of the molecular mechanisms
which could explain the gradient of vascularisation observed by us.
From the analysis of our in vitromodels model we propose, that
the interplay remains complex and no single factor is dominant at
all times in the spatio-temporal distribution of vessels in human
PDAC. Indeed, depleting stroma in murine PDAC models, via either
selective deletion of aSMA positive ﬁbroblasts or Sonic Hedgehog
(SHH) system in cancer cells, resulted in less differentiated, more
vascularised and more aggressive tumours with a worsening
overall survival in murine models [5,6]. Hence, modulating, rather
than ablating PDAC stromamay bemore useful strategy [8]. Current
attempts to target newly formed tumoral vessels functional stabi-
lization pathways (i.e. Notch/DLL or Semaphorins) could concep-
tually be more successful in view of our ﬁndings [29e31]. Further
studies are needed in order to identify selective markers of the
invasive front and the hypoxic core which may further mechanis-
tically implicate the differential vascular gradient.
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